Citations (127)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
M. A. Princz &
H. Sheardown. (2008) Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2). Journal of Biomaterials Science, Polymer Edition 19:9, pages 1201-1218.
Read now
Read now
Sébastien A. Gittens & Hasan Uludag. (2001) Growth Factor Delivery for Bone Tissue Engineering. Journal of Drug Targeting 9:6, pages 407-429.
Read now
Read now
John J. Lopez & Michael Simons. (1996) Local Extravascular Growth Factor Delivery in Myocardial Ischemia. Drug Delivery 3:3, pages 143-147.
Read now
Read now
Patricia A. D'amore & Sandra R. Smith. (1993) Growth Factor Effects on Cells of the Vascular Wall: A Survey. Growth Factors 8:1, pages 61-75.
Read now
Read now
Articles from other publishers (123)
Svenja Meissner, Brad Raos & Darren Svirskis. (2022) Hydrogels can control the presentation of growth factors and thereby improve their efficacy in tissue engineering. European Journal of Pharmaceutics and Biopharmaceutics 181, pages 1-21.
Crossref
Crossref
Yoshiro Ito, Ayako Oyane, Mayu Yasunaga, Koji Hirata, Motohiro Hirose, Hideo Tsurushima, Yuzuru Ito, Yuji Matsumaru & Eiichi Ishikawa. (2022) Induction of angiogenesis and neural progenitor cells by basic fibroblast growth factor‐releasing polyglycolic acid sheet following focal cerebral infarction in mice. Journal of Biomedical Materials Research Part A.
Crossref
Crossref
Patricio E. Ray, Jinliang Li, Jharna R. Das & Jing Yu. (2021) Association of circulating fibroblast growth factor-2 with progression of HIV-chronic kidney diseases in children. Pediatric Nephrology 36:12, pages 3933-3944.
Crossref
Crossref
Negar Azarpira, Maryam Kaviani & Fatemeh Sabet Sarvestani. (2021) Incorporation of VEGF-and bFGF-loaded alginate oxide particles in acellular collagen-alginate composite hydrogel to promote angiogenesis. Tissue and Cell 72, pages 101539.
Crossref
Crossref
Yuji Tanikawa, Akiko Obata, Kenji Nagata, Toshihiro Kasuga & Toshihisa Mizuno. (2021) Scaffolds Designing from Protein-loadable Coaxial Electrospun Fibermats of poly(acrylamide)-Co-poly(diacetone acrylamide) and Gelatin. Current Applied Polymer Science 4:2, pages 84-92.
Crossref
Crossref
Jannatul Fardous, Emiko Yamamoto, Yuji Omoso, Seiya Nagao, Yuuta Inoue, Kozue Yoshida, Yasuhiro Ikegami, Yi Zhang, Nana Shirakigawa, Fumiyasu Ono & Hiroyuki Ijima. (2021) Development of a gel-in-oil emulsion as a transdermal drug delivery system for successful delivery of growth factors. Journal of Bioscience and Bioengineering 132:1, pages 95-101.
Crossref
Crossref
Jiang Wu, Junyi Zhu, Qiuji Wu, Ying An, Kangning Wang, Tengxiao Xuan, Junwen Zhang, Wenxiang Song, Huacheng He, Liwan Song, Jie Zheng & Jian Xiao. (2021) Mussel-Inspired Surface Immobilization of Heparin on Magnetic Nanoparticles for Enhanced Wound Repair via Sustained Release of a Growth Factor and M2 Macrophage Polarization. ACS Applied Materials & Interfaces 13:2, pages 2230-2244.
Crossref
Crossref
Myung Jin Ban, Seung Chul Lee, Jae Hong Park, Ki Nam Park, Hee Kyung Kim & Seung Won Lee. (2020) Regenerative efficacy of fibroblast growth factor for the treatment of aged vocal fold: From animal model to clinical application. Clinical Otolaryngology 46:1, pages 131-137.
Crossref
Crossref
Elizabeth A. Mays, Sridula S. Kallakuri & Harini G. Sundararaghavan. (2020)
Heparin‐hyaluronic
acid nanofibers for growth factor sequestration in spinal cord repair
. Journal of Biomedical Materials Research Part A 108:10, pages 2023-2031.
Crossref
Crossref
Lilith M. Caballero Aguilar, Saimon M. Silva & Simon E. Moulton. (2019) Growth factor delivery: Defining the next generation platforms for tissue engineering. Journal of Controlled Release 306, pages 40-58.
Crossref
Crossref
Diana Gaspar, Rita Peixoto, Andrea De Pieri, Britta Striegl, Dimitrios I. Zeugolis & Michael Raghunath. (2019) Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs. Advanced Drug Delivery Reviews 146, pages 126-154.
Crossref
Crossref
Avid Najdahmadi, Jonathan R. T. Lakey & Elliot Botvinick. (2018) Structural Characteristics and Diffusion Coefficient of Alginate Hydrogels Used for Cell Based Drug Delivery. MRS Advances 3:40, pages 2399-2408.
Crossref
Crossref
Ayaka Tanaka, Hitomi Nakamura, Yasuhiko Tabata, Yuka Fujimori, Keiichi Kumasawa & Tadashi Kimura. (2018) Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen-thawed human ovarian tissue in a xenograft model. Journal of Obstetrics and Gynaecology Research.
Crossref
Crossref
Liancai Mu, Stanislaw Sobotka, Jingming Chen & Themba Nyirenda. (2017) Nerve growth factor and basic fibroblast growth factor promote reinnervation by nerve−muscle−endplate grafting. Muscle & Nerve 57:3, pages 449-459.
Crossref
Crossref
Xiaohua Yu, Adam H. Biedrzycki, Andrew S. Khalil, Dalton Hess, Jennifer M. Umhoefer, Mark D. Markel & William L. Murphy. (2017) Nanostructured Mineral Coatings Stabilize Proteins for Therapeutic Delivery. Advanced Materials 29:33, pages 1701255.
Crossref
Crossref
Alessandra Moscaroli, Gabriel Jones, Tessa Lühmann, Lorenz Meinel, Stephanie Wälti, Alain Blanc, Eliane Fischer, Manuel Hilbert, Roger Schibli & Martin Béhé. (2017)
Radiolabeled
111
In-FGF-2 Is Suitable for
In Vitro
/
Ex Vivo
Evaluations and
In Vivo
Imaging
. Molecular Pharmaceutics 14:3, pages 639-648.
Crossref
Crossref
Toshiki Kobayashi, Masanobu Mizuta, Nao Hiwatashi, Yo Kishimoto, Tatsuo Nakamura, Shin-ichi Kanemaru & Shigeru Hirano. (2017) Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar. Auris Nasus Larynx 44:1, pages 86-92.
Crossref
Crossref
Qian Lin, Ho Lun Wong, Fu-Rong Tian, Ya-Dong Huang, Jie Xu, Jing-Jing Yang, Pian-Pian Chen, Zi-Liang Fan, Cui-Tao Lu & Ying-Zheng Zhao. (2017) Enhanced neuroprotection with decellularized brain extracellular matrix containing bFGF after intracerebral transplantation in Parkinson’s disease rat model. International Journal of Pharmaceutics 517:1-2, pages 383-394.
Crossref
Crossref
Claire C. Chen, Linan Liu, Fengxia Ma, Chi W. Wong, Xuning E. Guo, Jenu V. Chacko, Henry P. Farhoodi, Shirley X. Zhang, Jan Zimak, Aude Ségaliny, Milad Riazifar, Victor Pham, Michelle A. Digman, Egest J. Pone & Weian Zhao. (2016) Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro. Cellular and Molecular Bioengineering 9:4, pages 509-529.
Crossref
Crossref
Samantha J. Paluck, Thi H. Nguyen, Jonghan P. Lee & Heather D. Maynard. (2016) A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2). Biomacromolecules 17:10, pages 3386-3395.
Crossref
Crossref
Patrick T.J. Hwang, Dong-Jin Lim, Timothy Fee, Grant C. Alexander, Ajay Tambralli, Adinarayana Andukuri, Liqun Tian, Wanxing Cui, Joel Berry, Shawn R. Gilbert & Ho-Wook Jun. (2016) A bio-inspired hybrid nanosack for graft vascularization at the omentum. Acta Biomaterialia 41, pages 224-234.
Crossref
Crossref
JIE QIN, LIN WANG, LING ZHENG, XIAOYAN ZHOU, YIDI ZHANG, TINGTING YANG & YANMIN ZHOU. (2016) Concentrated growth factor promotes Schwann cell migration partly through the integrin β1-mediated activation of the focal adhesion kinase pathway. International Journal of Molecular Medicine 37:5, pages 1363-1370.
Crossref
Crossref
Caitlin G. Decker, Yu Wang, Samantha J. Paluck, Lu Shen, Joseph A. Loo, Alex J. Levine, Lloyd S. Miller & Heather D. Maynard. (2016) Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing. Biomaterials 81, pages 157-168.
Crossref
Crossref
Sasan Sharee Ghourichaee & Jennie B. Leach. (2016) The effect of hypoxia and laminin-rich substrates on the proliferative behavior of human neural stem cells. Journal of Materials Chemistry B 4:20, pages 3509-3514.
Crossref
Crossref
Guang-Wei Zhang, Tian-Xiang Gu, Xiao-Yu Guan, Xue-Jun Sun, Xun Qi, Xue-Yuan Li, Xiao-Bing Wang, Lei Yu, Da-Qing Jiang, Rui Tang & Jesse Li-Ling. (2015) bFGF binding cardiac extracellular matrix promotes the repair potential of bone marrow mesenchymal stem cells in a rabbit model for acute myocardial infarction. Biomedical Materials 10:6, pages 065018.
Crossref
Crossref
Itay Levy, Ifat Sher, Enav Corem-Salkmon, Ofra Ziv-Polat, Amilia Meir, Avraham J Treves, Arnon Nagler, Ofra Kalter-Leibovici, Shlomo Margel & Ygal Rotenstreich. (2015) Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation. Journal of Nanobiotechnology 13:1.
Crossref
Crossref
Bing-Bing Yang, Brad Gillespie, Brian Smith, William Smith, Agneta Lissmats, Mattias Rudebeck, Torbj?rn Kullenberg & Birgitta Olsson. (2015) Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin. The Journal of Clinical Pharmacology 55:10, pages 1109-1118.
Crossref
Crossref
Nao Hiwatashi, Shigeru Hirano, Masanobu Mizuta, Ichiro Tateya, Shin-ichi Kanemaru, Tatsuo Nakamura, Juichi Ito, Katsuya Kawai & Shigehiko Suzuki. (2014) Biocompatibility and Efficacy of Collagen/Gelatin Sponge Scaffold With Sustained Release of Basic Fibroblast Growth Factor on Vocal Fold Fibroblasts in 3-Dimensional Culture. Annals of Otology, Rhinology & Laryngology 124:2, pages 116-125.
Crossref
Crossref
Xuefang Xie, Anamaris M. Colberg-Poley, Jharna R. Das, Jinliang Li, Aiping Zhang, Pingtao Tang, Marina Jerebtsova, J. Silvio Gutkind & Patricio E. Ray. (2014) The Basic Domain of HIV-Tat Transactivating Protein Is Essential for Its Targeting to Lipid Rafts and Regulating Fibroblast Growth Factor-2 Signaling in Podocytes Isolated from Children with HIV-1–Associated Nephropathy. Journal of the American Society of Nephrology 25:8, pages 1800-1813.
Crossref
Crossref
Ying-Zheng Zhao, Xing Li, Cui-Tao Lu, Min Lin, Li-Juan Chen, Qi Xiang, Ming Zhang, Rong-Rong Jin, Xi Jiang, Xiao-Tong Shen, Xiao-Kun Li & Jun Cai. (2014) Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats. Nanomedicine: Nanotechnology, Biology and Medicine 10:4, pages 755-764.
Crossref
Crossref
Azusa Shimizu, Satoshi Tajima, Morikuni Tobita, Rica Tanaka, Yasuhiko Tabata & Hiroshi Mizuno. (2014) Effect of Control-released Basic Fibroblast Growth Factor Incorporated in β-Tricalcium Phosphate for Murine Cranial Model. Plastic and Reconstructive Surgery Global Open 2:3, pages e126.
Crossref
Crossref
Ofra Ziv-Polat, Abraham Shahar, Itay Levy, Hadas Skaat, Sara Neuman, Federica Fregnan, Stefano Geuna, Claudia Grothe, Kirsten Haastert-Talini & Shlomo Margel. (2014)
The Role of Neurotrophic Factors Conjugated to Iron Oxide Nanoparticles in Peripheral Nerve Regeneration:
In Vitro
Studies
. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Xiupeng Wang, Ayako Oyane & Atsuo Ito. 2014. Advances in Calcium Phosphate Biomaterials. Advances in Calcium Phosphate Biomaterials
171
197
.
Risa Kigami, Shuichi Sato, Noriko Tsuchiya, Tomohiro Yoshimakai, Yoshinori Arai & Koichi Ito. (2013) FGF-2 Angiogenesis in Bone Regeneration Within Critical-Sized Bone Defects in Rat Calvaria. Implant Dentistry 22:4, pages 422-427.
Crossref
Crossref
Min Zhu, Steven R. Cohen, Kevin C. Hicok, Rob K. Shanahan, Brian M. Strem, Johnson C. Yu, Douglas M. Arm & John K. Fraser. (2013) Comparison of Three Different Fat Graft Preparation Methods. Plastic and Reconstructive Surgery 131:4, pages 873-880.
Crossref
Crossref
Thi H. Nguyen, Sung-Hye Kim, Caitlin G. Decker, Darice Y. Wong, Joseph A. Loo & Heather D. Maynard. (2013) A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor. Nature Chemistry 5:3, pages 221-227.
Crossref
Crossref
Yoshiro Ito, Hideo Tsurushima, Masayuki Sato, Atsuo Ito, Ayako Oyane, Yu Sogo & Akira Matsumura. (2013) Angiogenesis therapy for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor 2. Biochemical and Biophysical Research Communications 432:1, pages 182-187.
Crossref
Crossref
Yangjin Kim & Khalid Boushaba. 2013. Systems Biology of Tumor Dormancy. Systems Biology of Tumor Dormancy
237
259
.
Jessica I. MollmarkAndrew J.-H. ParkJustin KimThomas Z. WangSarah KatzenellSamantha L. ShipmanLyubomir G. ZagorchevMichael SimonsMary Jo Mulligan-Kehoe. (2012) Fibroblast Growth Factor-2 Is Required for Vasa Vasorum Plexus Stability in Hypercholesterolemic Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 32:11, pages 2644-2651.
Crossref
Crossref
Xiaolei Guo, Christopher G. Elliott, Zhenqing Li, Yanyi Xu, Douglas W. Hamilton & Jianjun Guan. (2012) Creating 3D Angiogenic Growth Factor Gradients in Fibrous Constructs to Guide Fast Angiogenesis. Biomacromolecules 13:10, pages 3262-3271.
Crossref
Crossref
Takashi Kitajima & Yoshihiro Ito. 2012. Handbook of Intelligent Scaffold for Tissue Engineering and Regenerative Medicine. Handbook of Intelligent Scaffold for Tissue Engineering and Regenerative Medicine
337
353
.
Atsushi Narita, Masatoshi Takahara, Daisuke Sato, Toshihiko Ogino, Shigenobu Fukushima, Yu Kimura & Yasuhiko Tabata. (2012) Biodegradable Gelatin Hydrogels Incorporating Fibroblast Growth Factor 2 Promote Healing of Horizontal Tears in Rabbit Meniscus. Arthroscopy: The Journal of Arthroscopic & Related Surgery 28:2, pages 255-263.
Crossref
Crossref
Neil H. DaviesChristian SchmidtDeon BezuidenhoutPeter Zilla. (2012) Sustaining Neovascularization of a Scaffold Through Staged Release of Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-BB. Tissue Engineering Part A 18:1-2, pages 26-34.
Crossref
Crossref
Khalid Boushaba & Yangjin Kim. (2010) An enzyme kinetics model of tumor dormancy, regulation of secondary metastases. Discrete and Continuous Dynamical Systems - Series S 4:6, pages 1465-1498.
Crossref
Crossref
Xiao-Cheng Liu, Jian Zhao, Ying Wang, Tian-Jun Liu, Feng Lü & Guo-Wei He. (2010) Heparin- and Basic Fibroblast Growth Factor-incorporated Stent: A New Promising Method for Myocardial Revascularization. Journal of Surgical Research 164:2, pages 204-213.
Crossref
Crossref
A. Zieris, S. Prokoph, P. B. Welzel, M. Grimmer, K. R. Levental, W. Panyanuwat, U. Freudenberg & C. Werner. (2009) Analytical approaches to uptake and release of hydrogel-associated FGF-2. Journal of Materials Science: Materials in Medicine 21:3, pages 915-923.
Crossref
Crossref
J.C.H. Goh & S. Sahoo. 2010. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues
452
468
.
Richard G. Jansen, Toin H. van Kuppevelt, Willeke F. Daamen, Anne M. Kuijpers-Jagtman & Johannes W. Von den Hoff. (2009) FGF-2-loaded collagen scaffolds attract cells and blood vessels in rat oral mucosa. Journal of Oral Pathology & Medicine 38:8, pages 630-638.
Crossref
Crossref
Atsushi Narita, Masatoshi Takahara, Toshihiko Ogino, Shigenobu Fukushima, Yu Kimura & Yasuhiko Tabata. (2009) Effect of gelatin hydrogel incorporating fibroblast growth factor 2 on human meniscal cells in an organ culture model. The Knee 16:4, pages 285-289.
Crossref
Crossref
Yu-Ping Ma, Min-Min Ma, Song-Ming Cheng, Hai-Han Ma, Xue-Ming Yi, Ge-Lin Xu & Xin-Feng Liu. (2008) Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia. Neuroscience Letters 437:2, pages 93-97.
Crossref
Crossref
Michael Fannon, Kimberly Forsten-Williams, Matthew A. Nugent, Kalvin J. Gregory, Chia Lin Chu, Adrienne L Goerges-Wildt, Dipak Panigrahy, Arja Kaipainen, Carmen Barnes, Cathy Lapp & Yuen Shing. (2008) Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: Potential for regulation of tumor growth. Journal of Cellular Physiology 215:2, pages 434-441.
Crossref
Crossref
James Melrose, Christine Chuang & John Whitelock. (2008) Tissue engineering of cartilages using biomatrices. Journal of Chemical Technology & Biotechnology 83:4, pages 444-463.
Crossref
Crossref
WonHyoung Ryu, Zhinong Huang, Fritz B. Prinz, Stuart B. Goodman & Rainer Fasching. (2007) Biodegradable micro-osmotic pump for long-term and controlled release of basic fibroblast growth factor. Journal of Controlled Release 124:1-2, pages 98-105.
Crossref
Crossref
Yanqiang Zhong, Li Zhang, Amy G. Ding, Anna Shenderova, Gaozhong Zhu, Ping Pei, Ruth R. Chen, Susan R. Mallery, David J. Mooney & Steven P. Schwendeman. (2007) Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/Poly(DL-lactic-co-glycolic acid) implants. Journal of Controlled Release 122:3, pages 331-337.
Crossref
Crossref
Joerg K. Tessmar & Achim M. Göpferich. (2007) Matrices and scaffolds for protein delivery in tissue engineering. Advanced Drug Delivery Reviews 59:4-5, pages 274-291.
Crossref
Crossref
Marina Jerebtsova, Edward Wong, Ronald Przygodzki, Pingtao Tang & Patricio E. Ray. (2007) A novel role of fibroblast growth factor-2 and pentosan polysulfate in the pathogenesis of intestinal bleeding in mice. American Journal of Physiology-Heart and Circulatory Physiology 292:2, pages H743-H750.
Crossref
Crossref
Khalid Boushaba, Howard A. Levinea & Marit Nilsen-Hamiltonb. (2006) A Mathematical Model for the Regulation of Tumor Dormancy Based on Enzyme Kinetics. Bulletin of Mathematical Biology 68:7, pages 1495-1526.
Crossref
Crossref
Alexander D. Augst, Hyun Joon Kong & David J. Mooney. (2006) Alginate Hydrogels as Biomaterials. Macromolecular Bioscience 6:8, pages 623-633.
Crossref
Crossref
Laura A Allen, Ronald L Terjung & H T Yang. (2006) Exogenous Basic Fibroblast Growth Factor Increases Collateral Blood Flow in Female Rats With Femoral Artery Occlusion. Journal of Cardiovascular Pharmacology 47:1, pages 146-154.
Crossref
Crossref
Pingtao Tang, Marina Jerebtsova, Ronald Przygodzki & Patricio E. Ray. (2005) Fibroblast growth factor-2 increases the renal recruitment and attachment of HIV-infected mononuclear cells to renal tubular epithelial cells. Pediatric Nephrology 20:12, pages 1708-1716.
Crossref
Crossref
Noritaka Isogai, Tadaaki Morotomi, Sumio Hayakawa, Hiroshi Munakata, Yasuhiko Tabata, Yoshito Ikada & Hiroshi Kamiishi. (2005) Combined chondrocyte-copolymer implantation with slow release of basic fibroblast growth factor for tissue engineering an auricular cartilage construct. Journal of Biomedical Materials Research Part A 74A:3, pages 408-418.
Crossref
Crossref
Asako Nakanishi, Arata Hakamada, Ken-ichi Isoda & Hitoshi Mizutani. (2005) Atelocollagen Sponge and Recombinant Basic Fibroblast Growth Factor Combination Therapy for Resistant Wounds with Deep Cavities. The Journal of Dermatology 32:5, pages 376-380.
Crossref
Crossref
Minoru Matsuura, Kazuichi Okazaki, Akiyoshi Nishio, Hiroshi Nakase, Hiroyuki Tamaki, Kazushige Uchida, Toshiki Nishi, Masanori Asada, Kimio Kawasaki, Toshiro Fukui, Hazuki Yoshizawa, Shinya Ohashi, Satoko Inoue, Chiharu Kawanami, Hiroshi Hiai, Yasuhiko Tabata & Tsutomu Chiba. (2005) Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 128:4, pages 975-986.
Crossref
Crossref
Shinya Fukuhara, Shinji Tomita, Takeshi Nakatani, Toshiya Fujisato, Yoshinori Ohtsu, Michiko Ishida, Chikao Yutani & Soichiro Kitamura. (2005) Current address: Shinji Tomita, MD, Cardiothoracic Surgical Unit, Level 4, Auckland City Hospital, Auckland, New Zealand. Circulation Journal 69:7, pages 850-857.
Crossref
Crossref
Matthew A. Nugent, Kimberly Forsten-Williams, Morris J. Karnovsky & Elazer R. Edelman. 2005. Chemistry and Biology of Heparin and Heparan Sulfate. Chemistry and Biology of Heparin and Heparan Sulfate
533
570
.
Geeti Bansal, Sébastien A. Gittens & Hasan Uludağ. (2004) A di(bisphosphonic acid) for protein coupling and targeting to bone. Journal of Pharmaceutical Sciences 93:11, pages 2788-2799.
Crossref
Crossref
Andreas H. Zisch, Matthias P. Lutolf & Jeffrey A. Hubbell. (2003) Biopolymeric delivery matrices for angiogenic growth factors. Cardiovascular Pathology 12:6, pages 295-310.
Crossref
Crossref
Zishan A. Haroon, Khalid Amin, Xiaohong Jiang & Murat O. Arcasoy. (2003) A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing Response. The American Journal of Pathology 163:3, pages 993-1000.
Crossref
Crossref
Anat Perets, Yaacov Baruch, Felix Weisbuch, Gideon Shoshany, Gera Neufeld & Smadar Cohen. (2003) Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. Journal of Biomedical Materials Research 65A:4, pages 489-497.
Crossref
Crossref
Michael FannonKimberly Forsten-WilliamsChristopher J. DowdDeborah A. FreedmanJudah FolkmanMatthew A. Nugent. (2003) Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment. The FASEB Journal 17:8, pages 1-20.
Crossref
Crossref
Charles-Edouard Luyt, Anne Meddahi-Pellé, Benoit Ho-Tin-Noe, Sylvia Colliec-Jouault, Jean Guezennec, Liliane Louedec, Hervé Prats, Marie-Paule Jacob, Mary Osborne-Pellegrin, Didier Letourneur & Jean-Baptiste Michel. (2003) Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia. Journal of Pharmacology and Experimental Therapeutics 305:1, pages 24-30.
Crossref
Crossref
Kuen Yong Lee, Martin C Peters & David J Mooney. (2003) Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. Journal of Controlled Release 87:1-3, pages 49-56.
Crossref
Crossref
J. S. Pieper, T. Hafmans, P. B. van Wachem, M. J. A. van Luyn, L. A. Brouwer, J. H. Veerkamp & T. H. van Kuppevelt. (2002) Loading of collagen‐heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. Journal of Biomedical Materials Research 62:2, pages 185-194.
Crossref
Crossref
Bi-Wei Song, Harry V. Vinters, Dafang Wu & William M. Pardridge. (2002) Enhanced Neuroprotective Effects of Basic Fibroblast Growth Factor in Regional Brain Ischemia after Conjugation to a Blood-Brain Barrier Delivery Vector. Journal of Pharmacology and Experimental Therapeutics 301:2, pages 605-610.
Crossref
Crossref
M.J.B Wissink, R Beernink, J.S Pieper, A.A Poot, G.H.M Engbers, T Beugeling, W.G van Aken & J Feijen. (2001) Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 22:16, pages 2291-2299.
Crossref
Crossref
Xue-Hui Liu, Achim Aigner, Anton Wellstein & Patricio E. Ray. (2001) Up-regulation of a fibroblast growth factor binding protein in children with renal diseases. Kidney International 59:5, pages 1717-1728.
Crossref
Crossref
Mark A. Bush, Emil Samara, M. J. Whitehouse, Carl Yoshizawa, Deborah L. Novicki, Marilyn Pike, Roger J. Laham, Michael Simons & Nicolas A. Chronos. (2013) Pharmacokinetics and Pharmacodynamics of Recombinant FGF‐2 in a Phase I Trial in Coronary Artery Disease. The Journal of Clinical Pharmacology 41:4, pages 378-385.
Crossref
Crossref
Diana K. Hoganson, Barbara A. Sosnowski, Glenn F. Pierce & John Doukas. (2001) Uptake of Adenoviral Vectors via Fibroblast Growth Factor Receptors Involves Intracellular Pathways That Differ from the Targeting Ligand. Molecular Therapy 3:1, pages 105-112.
Crossref
Crossref
Richard Baffour, Jane L. Garb, Jeffrey Kaufman, Joel Berman, Sang W. Rhee, Marc A. Norris & Paul Friedmann. (2000) Angiogenic Therapy for the Chronically Ischemic Lower Limb in a Rabbit Model. Journal of Surgical Research 93:2, pages 219-229.
Crossref
Crossref
Susan R. Mallery, Ping Pei, Jichao Kang, Gaozhong Zhu, Gregory M. Ness & Steven P. Schwendeman. (2000) Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts. Carcinogenesis 21:9, pages 1647-1653.
Crossref
Crossref
Lois A. Chandler, John Doukas, Ana Maria Gonzalez, Diana K. Hoganson, Dan-Ling Gu, Chenglie Ma, Mark Nesbit, Timothy M. Crombleholme, Meenhard Herlyn, Barbara A. Sosnowski & Glenn F. Pierce. (2000) FGF2-Targeted Adenovirus Encoding Platelet-Derived Growth Factor-B Enhances de Novo Tissue Formation. Molecular Therapy 2:2, pages 153-160.
Crossref
Crossref
H. T. Yang, Y. Feng, Laura A. Allen, Andrew Protter & Ronald L. Terjung. (2000) Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. American Journal of Physiology-Heart and Circulatory Physiology 278:6, pages H1966-H1973.
Crossref
Crossref
Ellis F Unger, Lino Goncalves, Stephen E Epstein, Emily Y Chew, Carol Braun Trapnell, Richard O CannonIIIIII, Arshed A Quyyumi, Francis Loscalzo & Jonathan A Stiber. (2000) Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. The American Journal of Cardiology 85:12, pages 1414-1419.
Crossref
Crossref
Ping De Niu, Dennis P Radman, Eva M Jaworski, Harminder Deol, Reiner Gentz, Jeffrey Su, Henrik S Olsen & Graham F Wagner. (2000) Development of a human stanniocalcin radioimmunoassay: serum and tissue hormone levels and pharmacokinetics in the rat. Molecular and Cellular Endocrinology 162:1-2, pages 131-144.
Crossref
Crossref
John Doukas, Diana K. Hoganson, Michael Ong, Wenbin Ying, David L. Lacey, Andrew Baird, Glenn F. Pierce & Barbara A. Sosnowski. (1999) Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways. The FASEB Journal 13:11, pages 1459-1466.
Crossref
Crossref
Michael Flanagan. 1999. Coronary Angiogenesis. Coronary Angiogenesis
215
279
.
Ruth L. Bush, William C. Pevec, Assan Ndoye, Anthony T.W. Cheung, Joachim Sasse & David N. Pearson. (1998) Regulation of new blood vessel growth into ischemic skeletal muscle. Journal of Vascular Surgery 28:5, pages 919-928.
Crossref
Crossref
Xiaobing Fu, Yinhui Yang, Xiaokun Li, Tongzhu Sun, Yaping Wang & Zhiyong Sheng. (1998) Ischemia and Reperfusion Impair the Gene Expression of Endogenous Basic Fibroblast Growth Factor (bFGF) in Rat Skeletal Muscles. Journal of Surgical Research 80:1, pages 88-93.
Crossref
Crossref
Zoya Galzie, Anne R Kinsella & John A Smith. (1997) Fibroblast growth factors and their receptors. Biochemistry and Cell Biology 75:6, pages 669-685.
Crossref
Crossref
Sylvie Colin, Frederic Mascarelli, Jean‐Claude Jeanny, Raymond Vienet, Gérard Bouche, Yves Courtois & Jean Labarre. (2004)
Comparative Study
In Vivo
and
In Vitro
of Uniformly
14
C‐Labelled and
125
I‐Labelled Recombinant Fibroblast Growth Factor 2
. European Journal of Biochemistry 249:2, pages 473-480.
Crossref
Crossref
M.E. Nimni. (1997) Polypeptide growth factors: targeted delivery systems. Biomaterials 18:18, pages 1201-1225.
Crossref
Crossref
JingMei Ren & Seth P Finklestein. (1997) Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia. European Journal of Pharmacology 327:1, pages 11-16.
Crossref
Crossref
Benjamin MedalionGideon MerinHelena AingornHua-Quan MiaoArnon NaglerAmir ElamiRivka Ishai-MichaeliIsrael Vlodavsky. (1997) Endogenous Basic Fibroblast Growth Factor Displaced by Heparin From the Lumenal Surface of Human Blood Vessels Is Preferentially Sequestered by Injured Regions of the Vessel Wall. Circulation 95:7, pages 1853-1862.
Crossref
Crossref
W. Mark Saltzman. (2013) Growth-Factor Delivery in Tissue Engineering. MRS Bulletin 21:11, pages 62-65.
Crossref
Crossref
Pamela Davol & A. Raymond Frackelton. (1996) The Mitotoxin, Basic Fibroblast Growth Factor-Saporin, Effectively Targets Human Prostatic Carcinoma in an Animal Model. The Journal of Urology, pages 1174-1179.
Crossref
Crossref
Pamela Davol & A. Raymond FrackeltonJr.Jr.. (1996) The Mitotoxin, Basic Fibroblast Growth Factor-Saporin, Effectively Targets Human Prostatic Carcinoma in an Animal Model. The Journal of Urology 156:3, pages 1174-1179.
Crossref
Crossref
H.T. YangMichael R. DeschenesRobert W. OgilvieRonald L. Terjung. (1996) Basic Fibroblast Growth Factor Increases Collateral Blood Flow in Rats With Femoral Arterial Ligation. Circulation Research 79:1, pages 62-69.
Crossref
Crossref
Grant E. Meyer, Enyou Yu, Justin A. Siegal, Jason C. Petteway, Brent A. Blumenstein & Michael K. Brawer. (1995) Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76:11, pages 2304-2311.
Crossref
Crossref
Yaacov Baruch, Gideon Shoshany, Gera Neufeld & Rafael Enat. (1995) Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. Journal of Hepatology 23:3, pages 328-332.
Crossref
Crossref
Daisy F. LazarousMickey ScheinowitzMatie ShouEverett HodgeM. A. Sharmini RajanayagamSally HunsbergerW. Gerald RobisonJrJrJonathan A. StiberRosaly CorreaStephen E. EpsteinEllis F. Unger. (1995) Effects of Chronic Systemic Administration of Basic Fibroblast Growth Factor on Collateral Development in the Canine Heart. Circulation 91:1, pages 145-153.
Crossref
Crossref
Patricio E. Ray, Leslie A. Bruggeman, Benjamin S. Weeks, Jeffrey B. Kopp, Joseph L. Bryant, Jennie W. Owens, Abner L. Notkins & Paul E. Klotman. (1994) bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney International 46:3, pages 759-772.
Crossref
Crossref
Andrew Baird. (2005) Potential mechanisms regulating the extracellular activities of basic fibroblast growth factor (FGF‐2). Molecular Reproduction and Development 39:1, pages 43-48.
Crossref
Crossref
Wenbin Ying, Darlene Martineau, Julie Beitz, Douglas A. Lappi & Andrew Baird. (1994) Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin. Cancer 74:3, pages 848-853.
Crossref
Crossref
M A NugentM J KarnovskyE R Edelman. (1993) Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.. Circulation Research 73:6, pages 1051-1060.
Crossref
Crossref
Ward Casscells, Douglas A. Lappi & Andrew Baird. (1993) Molecular atherectomy for restenosis. Trends in Cardiovascular Medicine 3:6, pages 235-243.
Crossref
Crossref
É. Sirois, M.F. Côté & C.J. Doillon. (2018) Growth Factors and Biological Supports for Endothelial Cell Lining: In Vitro Study. The International Journal of Artificial Organs 16:8, pages 609-619.
Crossref
Crossref
E.A. Mesri, R.J. Kreitman, Y.M. Fu, S.E. Epstein & I. Pastan. (1993) Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.. Journal of Biological Chemistry 268:7, pages 4853-4862.
Crossref
Crossref
J. W. van Neck & H. P. J. Bloemers. (1993) Molecular aspects of pathological processes in the artery wall. Molecular Biology Reports 17:1, pages 1-15.
Crossref
Crossref
Ward Casscells, Douglas A. Lappi & Andrew Baird. 1993. Growth Factors and the Cardiovascular System. Growth Factors and the Cardiovascular System
227
248
.
Richard Baffour, Joel Berman, Jane L. Garb, Sang Won Rhee, Jeffrey Kaufman & Paul Friedmann. (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. Journal of Vascular Surgery 16:2, pages 181-191.
Crossref
Crossref
J Folkman & Y Shing. (1992) Angiogenesis.. Journal of Biological Chemistry 267:16, pages 10931-10934.
Crossref
Crossref
Peter Rieck, Michael Assouline, Michele Savoldelli, Christian Hartmann, Claudine Jacob, Yves Pouliquen & Yves Courtois. (1992) Recombinant human basic fibroblast growth factor (Rh-bFGF) in three different wound models in rabbits: Corneal wound healing effect and pharmacology. Experimental Eye Research 54:6, pages 987-998.
Crossref
Crossref
Patricia A. D'Amore. (1992) Mechanisms of Endothelial Growth Control. American Journal of Respiratory Cell and Molecular Biology 6:1, pages 1-8.
Crossref
Crossref
Alan S. Rudolph, Geoffrey Stilwell, Richard O. Cliff, Brian Kahn, Barry J. Spargo, Florence Rollwagen & Rod L. Monroy. (1992) Biocompatibility of lipid microcylinders: effect on cell growth and antigen presentation in culture. Biomaterials 13:15, pages 1085-1092.
Crossref
Crossref
I. VLOAVSKY, P. BASHKIN, R. ISHAI-MICHAELI, T. CHAJEK-SHAUL, R. BAR-SHAVIT, A. HAIMOVITZ-FRIEDMAN, M. KLAGSBRUN & Z. FUKS. (1991) Sequestration and Release of Basic Fibroblast Growth Factor. Annals of the New York Academy of Sciences 638:1 The Fibroblas, pages 207-220.
Crossref
Crossref
Elazer R. Edelman, Edith Mathiowitz, Robert Langer & Michael Klagsbrun. (1991) Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12:7, pages 619-626.
Crossref
Crossref
Mark K. Lyons, Robert E. Anderson & Fredric B. Meyer. (1991) Basic fibroblast growth factor promotes in vivo cerebral angiogenesis in chronic forebrain ischemia. Brain Research 558:2, pages 315-320.
Crossref
Crossref
S BanaiM T JaklitschW CasscellsM ShouS ShrivastavR CorreaS E EpsteinE F Unger. (1991) Effects of acidic fibroblast growth factor on normal and ischemic myocardium.. Circulation Research 69:1, pages 76-85.
Crossref
Crossref
Isabelle Dabin & Yves Courtois. (2005) In vitro kinetics of basic fibroblast growth factor diffusion across a reconstituted corneal endothelium. Journal of Cellular Physiology 147:3, pages 396-402.
Crossref
Crossref
Douglas A. Lappi, Pamela A. Maher, Darlene Martineau & Andrew Baird. (2005) The basic fibroblast growth factor‐saporin mitotoxin acts through the basic fibroblast growth factor receptor. Journal of Cellular Physiology 147:1, pages 17-26.
Crossref
Crossref
Matthew A. Nugent, Oliver S. Chen & Elazer R. Edelman. (2011) Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture. MRS Proceedings 252.
Crossref
Crossref
V LindnerD A LappiA BairdR A MajackM A Reidy. (1991) Role of basic fibroblast growth factor in vascular lesion formation.. Circulation Research 68:1, pages 106-113.
Crossref
Crossref
Patricia A. D'Amore. (1990) Modes of FGF release in vivo and in vitro. CANCER AND METASTASIS REVIEW 9:3, pages 227-238.
Crossref
Crossref